Total Number of Voting Rights and Share Capital in Novo Nordisk A/S as of 30 April 2013

Published: Apr 30, 2013

BAGSVAERD, DENMARK--(Marketwired - April 30, 2013) -


Company announcement No 31 2013: http://hugin.info/2013/R/1697868/559662.pdf

This announcement is distributed by Thomson Reuters on behalf of Thomson Reuters clients. The owner of this announcement warrants that:

(i)  the releases contained herein are protected by copyright and
     other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
     originality of the information contained therein.

Source: Novo Nordisk A/S via Thomson Reuters ONE [HUG#1697868]


Further information:
Media:
Anne Margrethe Hauge
Tel: +45 4442 3450
Email Contact

Ken Inchausti (US)
Tel: +1 609 514 8316
Email Contact

Investors:
Kasper Roseeuw Poulsen
Tel: +45 4442 4303
Email Contact

Frank Daniel Mersebach
Tel: +45 4442 0604
Email Contact

Lars Borup Jacobsen
Tel: +45 3075 3479
Email Contact

Jannick Lindegaard (US)
Tel: +1 609 786 4575
Email Contact

Back to news